Skip to main content
Top

Current Hypertension Reports

Issue 1/2015

Content (9 Articles)

Open Access Antihypertensive Agents: Mechanisms of Drug Action (M Ernst, Section Editor)

Preventing the Progression of Prehypertension to Hypertension: Role of Antihypertensives

Flávio Danni Fuchs, Renato Bandeira de Mello, Sandra Costa Fuchs

Antihypertensive Agents: Mechanisms of Drug Action (M Ernst, Section Editor)

Plasma Renin Testing to Guide Antihypertensive Therapy

Anthony J. Viera, Curt D. Furberg

Antihypertensive Agents: Mechanisms of Drug Action (M Ernst, Section Editor)

Inflammation and Hypertension: New Understandings and Potential Therapeutic Targets

Carmen De Miguel, Nathan P. Rudemiller, Justine M. Abais, David L. Mattson

Antihypertensive Agents: Mechanisms of Drug Action (M Ernst, Section Editor)

Vasopressin Receptor Antagonists

Biff F. Palmer

Antihypertensive Agents: Mechanisms of Drug Action (M Ernst, Section Editor)

Dual Renin-Angiotensin-Aldosterone Blockade: Promises and Pitfalls

Steven G. Chrysant, George S. Chrysant

Pediatric Hypertension (B Falkner, Section Editor)

Cognitive Function in Hypertensive Children

Marc B. Lande, Juan C. Kupferman

Pediatric Hypertension (B Falkner, Section Editor)

Familial Aggregation and Childhood Blood Pressure

Xiaoling Wang, Xiaojing Xu, Shaoyong Su, Harold Snieder

Pediatric Hypertension (B Falkner, Section Editor)

Treatment of Hypertension in Children with Chronic Kidney Disease

Susan Halbach, Joseph Flynn

Hypertension and Obesity (E Reisin, Section Editor)

Hypertension and Insulin Resistance: Implications of Mitochondrial Dysfunction

Walter Manucha, Bob Ritchie, León Ferder

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.